文献速递精神分裂症与精神病性障碍

人脑共表达网络分析识别与优先排序精神分裂症风险相关基因集

Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain.
PubMed 文献 · Mol Psychiatry · 2018-11-26

该研究应用加权基因共表达网络分析(WGCNA)处理来自LIBD死后人脑库的背外侧前额叶(DLPFC)RNA-Seq数据(90例对照,74例精神分裂症病例,均为高加索人),构建共表达网络并检测共表达基因模块。研究发现一个模块同时与精神分裂症诊断和多基因风险评分(PRS)显著相关,并与36个PGC2 loci基因显著重叠,该模块富集突触信号和神经可塑性相关基因,被认为是药物靶点的最强候选。

要点

  • 一个共表达模块同时与精神分裂症诊断和PRS显著相关,并与36个PGC2 loci基因重叠。
  • 该模块富集突触信号和神经可塑性相关基因,为最强药物靶点候选。

核心结论

  • 精神分裂症遗传信号与共表达模块的关联汇聚于一个模块,该模块与诊断和PRS均显著相关并与36个PGC2 loci基因显著重叠。

研究设计与样本

  • 研究对LIBD死后人脑库的DLPFC RNA-Seq数据(90例对照,74例精神分裂症病例,均为高加索人)应用WGCNA构建共表达网络并检测模块。

主要发现

  • 一个模块不仅与诊断和PRS均显著相关,还与36个PGC2 loci基因显著重叠,该模块包含许多参与突触信号和神经可塑性的基因。

临床怎么用

  • 该研究提供了一种利用脑共表达网络信息选择和优先排序潜在可成药基因集的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Schizophrenia polygenic risk is plausibly manifested by complex transcriptional dysregulation in the brain, involving networks of co-expressed and functionally related genes. The main purpose of this study was to identify and prioritize co-expressed gene sets in a hierarchical manner, based on the strength of the relationships with clinical diagnosis and with polygenic risk for schizophrenia. Weighted Gene Co-expression Network Analysis (WGCNA) was applied to RNA-quality-adjusted DLPFC RNA-Seq data from the LIBD Postmortem Human Brain Repository (90 controls, 74 schizophrenia cases; all Caucasians) to construct co-expression networks and detect "modules" of co-expressed genes. After multiple internal and external validation procedures, modules of selected interest were tested for enrichment in biological ontologies, for association with schizophrenia polygenic risk scores (PRSs) and with diagnosis, and also for enrichment in genes within the significant GWAS loci reported by the Psychiatric Genomic Consortium (PGC2). The association between schizophrenia genetic signals and modules of co-expression converged on one module showing not only a significant association with both diagnosis and PRS but also significant overlap with 36 PGC2 loci genes, deemed the strongest candidates for drug targets. This module contained many genes involved in synaptic signaling and neuroplasticity. Fifty-three PGC2 genes were in modules associated only with diagnosis and 59 in modules unrelated to diagnosis or PRS. Our study highlights complex relationships between gene co-expression networks in the brain and clinical state and polygenic risk for SCZ and provides a strategy for using this information in selecting and prioritizing potentially targetable gene sets for therapeutic drug development.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Radulescu E, Jaffe AE, Straub RE, et al. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry. 2018. PMID: 30478419. doi:10.1038/s41380-018-0304-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。